Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats
Yan Li, Kasper F. Raaby, Connie Sanchéz, et al.
Behavioural Brain Research (2013) Vol. 256, pp. 520-528
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods
Cláudia Barth, Arno Villringer, Julia Sacher
Frontiers in Neuroscience (2015) Vol. 9
Open Access | Times Cited: 566
Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
Connie Sanchéz, Karen E. Asin, Francesc Artigas
Pharmacology & Therapeutics (2014) Vol. 145, pp. 43-57
Open Access | Times Cited: 461
Animal models of major depression: drawbacks and challenges
Barbara Planchez, Alexandre Surget, Catherine Belzung
Journal of Neural Transmission (2019) Vol. 126, Iss. 11, pp. 1383-1408
Open Access | Times Cited: 356
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
Elena Dale, Benny Bang‐Andersen, Connie Sanchéz
Biochemical Pharmacology (2015) Vol. 95, Iss. 2, pp. 81-97
Open Access | Times Cited: 214
Progesterone – Friend or foe?
Inger Sundström Poromaa, Erika Comasco, Rachael L. Sumner, et al.
Frontiers in Neuroendocrinology (2020) Vol. 59, pp. 100856-100856
Open Access | Times Cited: 128
Vortioxetine: a novel antidepressant for the treatment of major depressive disorder
Xénia Gonda, Samata Sharma, Frank I. Tarazi
Expert Opinion on Drug Discovery (2018) Vol. 14, Iss. 1, pp. 81-89
Closed Access | Times Cited: 98
Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression
Kristian Gaarn du Jardin, Nico Liebenberg, Heidi Kaastrup Müller, et al.
Psychopharmacology (2016) Vol. 233, Iss. 14, pp. 2813-2825
Closed Access | Times Cited: 74
Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice
Yan Li, Aicha Abdourahman, Joseph A. Tamm, et al.
Pharmacology Biochemistry and Behavior (2015) Vol. 135, pp. 70-82
Open Access | Times Cited: 73
Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research
Djamila Bennabi, Émmanuel Haffen, Vincent Van Waes
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 61
Exploring role of natural compounds in molecular alterations associated with brain ageing: A perspective towards nutrition for ageing brain
Nazia Siddiqui, Alok Sharma, Anuradha Kesharwani, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102282-102282
Closed Access | Times Cited: 6
Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant
Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, Paulina Misztak, et al.
Pharmacological Reports (2017) Vol. 69, Iss. 4, pp. 595-601
Closed Access | Times Cited: 61
Vortioxetine: First Global Approval
Andrew Gibb, Emma D. Deeks
Drugs (2013) Vol. 74, Iss. 1, pp. 135-145
Closed Access | Times Cited: 59
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive‐like behaviour in theWAG/Rij rat model of absence epilepsy
Rita Citraro, Antonio Leo, Pasquale De Fazio, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 12, pp. 3177-3188
Open Access | Times Cited: 53
New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder
Cornelius Katona, Cara Katona
Neuropsychiatric Disease and Treatment (2014), pp. 349-349
Open Access | Times Cited: 52
Sex steroid hormones and brain function:PETimaging as a tool for research
Rodrigo Moraga‐Amaro, Aren van Waarde, Janine Doorduin, et al.
Journal of Neuroendocrinology (2017) Vol. 30, Iss. 2
Open Access | Times Cited: 51
Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review
Javier de Diego-Adeliño, José Manuel Crespo, Fernando A. Lázaro Mora, et al.
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 5, pp. 673-690
Open Access | Times Cited: 40
Maternal neuroplasticity and mental health during the transition to motherhood
Natalia Chechko, Susanne Nehls
Nature Mental Health (2025)
Closed Access
Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression‐like behavior
Amanda Eskelund, Yan Li, David P. Budac, et al.
Journal of Neurochemistry (2017) Vol. 142, Iss. 1, pp. 118-131
Open Access | Times Cited: 43
Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats
Bin Tian, Xuelong Wang, Ya Huang, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 40
Amitriptyline reverses hyperalgesia and improves associated mood-like disorders in a model of experimental monoarthritis
Diana Amorim, Ana David-Pereira, Antti Pertovaara, et al.
Behavioural Brain Research (2014) Vol. 265, pp. 12-21
Open Access | Times Cited: 38
Puerarin ameliorated the behavioral deficits induced by chronic stress in rats
Zhi-Kun Qiu, Guanhua Zhang, De-Sheng Zhong, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 36
The 5-HT7 receptor system as a treatment target for mood and anxiety disorders: A systematic review
Natalie Gottlieb, Tse-Yi Li, Allan H. Young, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 12, pp. 1167-1181
Open Access | Times Cited: 9
A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex
Kristian Gaarn du Jardin, Heidi Kaastrup Müller, Connie Sanchéz, et al.
European Journal of Pharmacology (2016) Vol. 786, pp. 29-35
Closed Access | Times Cited: 27
Prenatal Exposure to Bisphenols and Phthalates and Postpartum Depression: The Role of Neurosteroid Hormone Disruption
Melanie H. Jacobson, Cheryl R. Stein, Mengling Liu, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 7, pp. 1887-1899
Open Access | Times Cited: 21
Paeonol at Certain Doses Alleviates Aggressive and Anxiety-Like Behaviours in Two Premenstrual Dysphoric Disorder Rat Models
Hao Zhang, Xiwen Geng, Zifa Li, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top